North China Pharmaceutical Group Xiantai Pharmaceutical

North China Pharmaceutical Group Xiantai Pharmaceutical is an active Chinese pharmaceutical manufacturing company within the North China Pharmaceutical group. The company appears to focus primarily on commercialized small-molecule active pharmaceutical ingredients and related pharmaceutical manufacturing rather than a novel-drug development pipeline. Publicly visible information links Xiantai to sterile and non-sterile antibiotic APIs including penicillin-series products, ampicillin sodium, and amoxicillin, as well as regulatory manufacturing approvals and GMP inspections. It is best characterized as a manufacturing and industrial pharma subsidiary serving domestic and export markets, with strengths in antibiotic raw materials and compliance-oriented production. The available evidence does not indicate that Xiantai is a venture-backed biotech platform company or a clinical-stage innovator.